Works by Oh, Do-Youn

Results: 151

Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

Published in:

Cell Communication & Signaling, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12964-025-02242-8

By:

Lee, Su In;
Nam, Ah-Rong;
Oh, Kyoung-Seok;
Kim, Jae-Min;
Bang, Ju-Hee;
Jeong, Yoojin;
Choo, Sea Young;
Kim, Hyo Jung;
Yoon, Jeesun;
Kim, Tae-Yong;
Oh, Do-Youn

Publication type:

Article

Optimal timing of surgery after neoadjuvant treatment in borderline resectable pancreatic cancer.

Published in:

Journal of Hepato -- Biliary -- Pancreatic Sciences, 2024, v. 31, n. 10, p. 737, doi. 10.1002/jhbp.12049

By:

Jung, Hye‐Sol;
Kwon, Wooil;
Yun, Won‐Gun;
Paik, Woo Hyun;
Hyub Lee, Sang;
Ryu, Ji Kon;
Oh, Do‐Youn;
Lee, Kyoung Bun;
Chie, Eui Kyu;
Jang, Jin‐Young

Publication type:

Article

Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapy.

Published in:

Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 1, p. 111, doi. 10.1002/jhbp.1050

By:

Lee, Mirang;
Kang, Jae Seung;
Kim, Hongbeom;
Kwon, Wooil;
Lee, Sang Hyub;
Ryu, Ji Kon;
Kim, Yong‐Tae;
Oh, Do‐Youn;
Chie, Eui Kyu;
Jang, Jin‐Young

Publication type:

Article

Role of surgical resection in the era of FOLFIRINOX for advanced pancreatic cancer.

Published in:

Journal of Hepato -- Biliary -- Pancreatic Sciences, 2019, v. 26, n. 9, p. 416, doi. 10.1002/jhbp.648

By:

Byun, Yoonhyeong;
Han, Youngmin;
Kang, Jae Seung;
Choi, Yoo Jin;
Kim, Hongbeom;
Kwon, Wooil;
Kim, Sun‐Whe;
Oh, Do‐Youn;
Lee, Sang Hyub;
Ryu, Ji Kon;
Kim, Yong‐Tae;
Jang, Jin‐Young

Publication type:

Article

Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 study.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 1717, doi. 10.2147/OTT.S182259

By:

Yao, James C;
Oh, Do-Youn;
Qian, Jiaming;
Park, Young Suk;
Herbst, Fabian;
Ridolfi, Antonia;
Izquierdo, Miguel;
Ito, Tetsuhide;
Jia, Liqun;
Komoto, Izumi;
Sriuranpong, Virote;
Shimada, Yasuhiro

Publication type:

Article

Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103).

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 5, p. 544, doi. 10.1002/jcph.2397

By:

Garralda, Elena;
Oh, Do Youn;
Italiano, Antoine;
Bedard, Philippe L.;
Delord, Jean‐Pierre;
Calvo, Emiliano;
LoRusso, Patricia;
Wainberg, Zev;
Cervantes, Andres;
Rodriguez‐Vida, Alejo;
Shemesh, Colby S.;
Sane, Rucha;
Mendus, Diana;
Ding, Hao;
Hendricks, Robert;
Meng, Ray;
Cho, Byoung Chul;
Kim, Tae Won;
Wu, Benjamin

Publication type:

Article

Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution.

Published in:

World Journal of Surgery, 2018, v. 42, n. 10, p. 3294, doi. 10.1007/s00268-018-4692-9

By:

Jang, Bum-Sup;
Park, Hae Jin;
Kim, Kyubo;
Jang, Jin-Young;
Kim, Sun Whe;
Oh, Do-Youn;
Chie, Eui Kyu

Publication type:

Article

Delayed Separation of Kaplan–Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis: Delayed Separation of KM Curves with Anti-PD-(L)1 Therapy: D.-Y. Oh et al

Published in:

Targeted Oncology, 2025, v. 20, n. 1, p. 45, doi. 10.1007/s11523-024-01108-2

By:

Oh, Do-Youn;
Rokutanda, Nana;
Żotkiewicz, Magdalena;
He, Philip;
Stocks, Jennifer;
Johnson, Melissa L.

Publication type:

Article

Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.

Published in:

2017

By:

Lim, Yu;
Koh, Jaemoon;
Kim, Kyubo;
Chie, Eui;
Kim, Sehui;
Lee, Kyoung;
Jang, Jin-Young;
Kim, Sun Whe;
Oh, Do-Youn;
Bang, Yung-Jue;
Lim, Yu Jin;
Chie, Eui Kyu;
Lee, Kyoung Bun

Publication type:

journal article

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.

Published in:

2014

By:

Kim, Dong-Wan;
Oh, Do-Youn;
Shin, Seong Hoon;
Kang, Jin Hyoung;
Cho, Byoung Chul;
Chung, Joo-Seop;
Kim, HyeJin;
Park, Keon Uk;
Kwon, Jung Hye;
Han, Ji-Youn;
Kim, Mi-Jung;
Bang, Yung-Jue

Publication type:

journal article

Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.

Published in:

2011

By:

Lee, Yun-Gyoo;
Han, Sae-Won;
Oh, Do-Youn;
Chie, Eui Kyu;
Jang, Jin-Young;
Im, Seock-Ah;
Kim, Tae-You;
Kim, Sun-Whe;
Ha, Sung Whan;
Bang, Yung-Jue

Publication type:

journal article

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

Published in:

2008

By:

Kim MJ;
Oh DY;
Lee SH;
Kim DW;
Im SA;
Kim TY;
Heo DS;
Bang YJ;
Kim, Mi-Jung;
Oh, Do-Youn;
Lee, Se-Hoon;
Kim, Dong-Wan;
Im, Seock-Ah;
Kim, Tae-You;
Heo, Dae Seog;
Bang, Yung-Jue

Publication type:

journal article

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.

Published in:

2008

By:

Keam B;
Im SA;
Han SW;
Ham HS;
Kim MA;
Oh DY;
Lee SH;
Kim JH;
Kim DW;
Kim TY;
Heo DS;
Kim WH;
Bang YJ;
Keam, Bhumsuk;
Im, Seock-Ah;
Han, Sae-Won;
Ham, Hye Seon;
Kim, Min A;
Oh, Do-Youn;
Lee, Se-Hoon

Publication type:

journal article

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.

Published in:

Supportive Care in Cancer, 2012, v. 20, n. 2, p. 395, doi. 10.1007/s00520-011-1126-8

By:

Kim, Jin;
Cha, Yongjun;
Kim, Su-Jung;
Han, Sae-Won;
Oh, Do-Youn;
Lee, Se-Hoon;
Kim, Dong-Wan;
Im, Seock-Ah;
Kim, Tae-You;
Heo, Dae;
Bang, Yung-Jue

Publication type:

Article

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

Published in:

Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 707, doi. 10.1007/s00432-015-2072-5

By:

Kim, Hyori;
Youk, Jeonghwan;
Yang, Yaewon;
Kim, Tae-Yong;
Min, Ahrum;
Ham, Hye-Seon;
Cho, Seongcheol;
Lee, Kyung-Hun;
Keam, Bhumsuk;
Han, Sae-Won;
Oh, Do-Youn;
Ryu, Han;
Han, Wonshik;
Park, In;
Kim, Tae-You;
Noh, Dong-Young;
Im, Seock-Ah

Publication type:

Article

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy.

Published in:

Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 9, p. 1301, doi. 10.1007/s00432-011-0991-3

By:

Keam, Bhumsuk;
Im, Seock-Ah;
Park, Sohee;
Nam, Byung-Ho;
Han, Sae-Won;
Oh, Do-Youn;
Kim, Jee;
Lee, Se-Hoon;
Han, Wonshik;
Kim, Dong-Wan;
Kim, Tae-You;
Park, In;
Noh, Dong-Young;
Heo, Dae;
Bang, Yung-Jue

Publication type:

Article

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.

Published in:

Gastric Cancer, 2019, v. 22, n. 5, p. 932, doi. 10.1007/s10120-019-00943-x

By:

Park, Ji Eun;
Jin, Mei Hua;
Hur, Minkyu;
Nam, Ah-Rong;
Bang, Ju-Hee;
Won, Jonghwa;
Oh, Do-Youn;
Bang, Yung-Jue

Publication type:

Article

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

Published in:

Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1

By:

Jung, Minkyu;
Ryu, Min-Hee;
Oh, Do Youn;
Kang, Myounghee;
Zang, Dae Young;
Hwang, In Gyu;
Lee, Keun-Wook;
Kim, Ki Hyang;
Shim, Byoung Yong;
Song, Eun Kee;
Sym, Sun Jin;
Han, Hye Sook;
Park, Young Lee;
Kim, Jin Soo;
Lee, Hyun Woo;
Lee, Moon Hee;
Koo, Dong-Hoe;
Song, Hong Suk;
Lee, Namsu;
Yang, Sung Hyun

Publication type:

Article

Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.

Published in:

Gastric Cancer, 2017, v. 20, n. 2, p. 254, doi. 10.1007/s10120-016-0613-5

By:

Lee, Kyung-Hun;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue;
Oh, Do-Youn;
Ock, Chan-Young;
Kim, Tae-Yong;
Nam, Ah-Rong;
Bang, Ju-Hee;
Lee, Joongyub

Publication type:

Article

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.

Published in:

Gastric Cancer, 2017, v. 20, n. 1, p. 164, doi. 10.1007/s10120-015-0583-z

By:

Ock, Chan-Young;
Nam, Ah-Rong;
Bang, Ju-Hee;
Kim, Tae-Yong;
Lee, Kyung-Hun;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue;
Oh, Do-Youn

Publication type:

Article

Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.

Published in:

Gastric Cancer, 2016, v. 19, n. 4, p. 1095, doi. 10.1007/s10120-015-0567-z

By:

Oh, Do-Youn;
Lee, Kewn-Wook;
Cho, Jae;
Kang, Won;
Im, Seock-Ah;
Kim, Jin;
Bang, Yung-Jue

Publication type:

Article

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer.

Published in:

Gastric Cancer, 2016, v. 19, n. 2, p. 597, doi. 10.1007/s10120-015-0481-4

By:

Ock, Chan-Young;
Oh, Do-Youn;
Lee, Joongyub;
Kim, Tae-Yong;
Lee, Kyung-Hun;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue

Publication type:

Article

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications.

Published in:

Gastric Cancer, 2016, v. 19, n. 2, p. 421, doi. 10.1007/s10120-015-0504-1

By:

Ock, Chan-Young;
Kim, Tae-Yong;
Lee, Kyung-Hun;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue;
Oh, Do-Youn

Publication type:

Article

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival.

Published in:

Gastric Cancer, 2013, v. 16, n. 4, p. 581, doi. 10.1007/s10120-012-0227-5

By:

Kang, Eun;
Im, Seock-Ah;
Oh, Do-Youn;
Han, Sae-Won;
Kim, Jin-Soo;
Choi, In;
Kim, Jin;
Kim, Yu;
Kim, Jee;
Kim, Tae-You;
Lee, Jong;
Bang, Yung-Jue;
Lee, Keun-Wook

Publication type:

Article

Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing

Published in:

PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064271

By:

Han, Sae-Won;
Kim, Hwang-Phill;
Shin, Jong-Yeon;
Jeong, Eun-Goo;
Lee, Won-Chul;
Lee, Kyung-Hun;
Won, Jae-Kyung;
Kim, Tae-Yong;
Oh, Do-Youn;
Im, Seock-Ah;
Bang, Yung-Jue;
Jeong, Seung-Yong;
Park, Kyu Joo;
Park, Jae-Gahb;
Kang, Gyeong Hoon;
Seo, Jeong-Sun;
Kim, Jong-Il;
Kim, Tae-You

Publication type:

Article

Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.

Published in:

Breast Cancer (13406868), 2014, v. 21, n. 4, p. 387, doi. 10.1007/s12282-012-0417-3

By:

Lee, Hyun;
Kim, Dae;
Keam, Bhumsuk;
Lee, Jeong;
Han, Sae-Won;
Oh, Do-Youn;
Yoon, Jung;
Kim, Tae-You;
Kim, Yu;
Lee, Keun;
Kim, Jin-Wook;
Jeong, Sook-Hyang;
Lee, Jong;
Kim, Jee;
Im, Seock-Ah

Publication type:

Article

Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.

Published in:

Breast Cancer (13406868), 2013, v. 20, n. 2, p. 167, doi. 10.1007/s12282-011-0323-0

By:

Keam, Bhumsuk;
Im, Seock-Ah;
Koh, Youngil;
Han, Sae-Won;
Oh, Do-Youn;
Cho, Nariya;
Kim, Jee;
Han, Wonshik;
Kang, Keon;
Moon, Woo;
Kim, Tae-You;
Park, In;
Noh, Dong-Young;
Chung, June-Key;
Bang, Yung-Jue

Publication type:

Article

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.

Published in:

2017

By:

Keam, Bhumsuk;
Kim, Min‐Kyung;
Choi, Yunhee;
Choi, Su‐Jin;
Choe, Pyoeng Gyun;
Lee, Kyung‐Hun;
Kim, Tae Min;
Kim, Tae‐Yong;
Oh, Do‐Youn;
Kim, Dong‐Wan;
Im, Seock‐Ah;
Kim, Nam‐Joong;
Heo, Dae Seog;
Park, Wan Beom;
Oh, Myoung‐don

Publication type:

journal article

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.

Published in:

Cancer (0008543X), 2012, v. 118, n. 24, p. 6162, doi. 10.1002/cncr.27675

By:

Oh, Do-Youn;
Kim, Tae-Won;
Park, Young Suk;
Shin, Sang Joon;
Shin, Seong Hoon;
Song, Eun-Kee;
Lee, Hyo Jin;
Lee, Kewn-wook;
Bang, Yung-Jue

Publication type:

Article

Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.

Published in:

2016

By:

Lee, Dong;
Kim, Se;
Im, Seock-Ah;
Oh, Do-Youn;
Kim, Tae-Yong;
Han, Joon;
Lee, Dong Ho;
Kim, Se Hyung;
Han, Joon Koo

Publication type:

journal article

ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy.

Published in:

Oncology, 2012, v. 83, n. 4, p. 218, doi. 10.1159/000341359

By:

Kim, Ji-Won;
Kim, Jee Hyun;
Im, Seock-Ah;
Kim, Yu Jung;
Han, Hye-Suk;
Kim, Jin-Soo;
Han, Sae-Won;
Jeon, Yoon Kyung;
Oh, Do-Youn;
Han, Wonshik;
Kim, Tae-You;
Park, In Ae;
Noh, Dong-Young;
Bang, Yung-Jue

Publication type:

Article

Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer.

Published in:

Oncology, 2012, v. 83, n. 2, p. 57, doi. 10.1159/000338795

By:

Lim, Kyu-Hyoung;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue

Publication type:

Article

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study.

Published in:

Cancer Science, 2020, v. 111, n. 2, p. 513, doi. 10.1111/cas.14264

By:

Bang, Yung‐Jue;
Li, Chung‐Pin;
Lee, Kyung‐Hun;
Chiu, Chang‐Fang;
Park, Joon Oh;
Shan, Yan‐Shen;
Kim, Jun Suk;
Chen, Jen‐Shi;
Shim, Hyun‐Jeong;
Rau, Kun‐Ming;
Choi, Hye Jin;
Oh, Do‐Youn;
Belanger, Bruce;
Chen, Li‐Tzong

Publication type:

Article

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.

Published in:

Cancer Science, 2015, v. 106, n. 1, p. 86, doi. 10.1111/cas.12560

By:

Kim, Hee‐Jun;
Im, Seock‐Ah;
Keam, Bhumsuk;
Ham, Hye Seon;
Lee, Kyung Hun;
Kim, Tae Yong;
Kim, Yu Jung;
Oh, Do‐Youn;
Kim, Jee Hyun;
Han, Wonshik;
Jang, In‐Jin;
Kim, Tae‐You;
Park, In Ae;
Noh, Dong Young

Publication type:

Article

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins.

Published in:

Cancer Science, 2011, v. 102, n. 7, p. 1388, doi. 10.1111/j.1349-7006.2011.01944.x

By:

Lee, Kyung-Hun;
Lee, Ju-Hee;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Oh, Do-Youn;
Bang, Yung-Jue

Publication type:

Article

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.

Published in:

Cancer Science, 2010, v. 101, n. 3, p. 793, doi. 10.1111/j.1349-7006.2009.01447.x

By:

Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Park, Sook Ryun;
Lee, Keun-Wook;
Song, Hong Suk;
Lee, Nam-Su;
Lee, Kyung Hee;
Choi, In Sil;
Lee, Moon Hee;
Kim, Min A;
Kim, Woo Ho;
Bang, Yung-Jue;
Kim, Tae-You

Publication type:

Article

Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-024-04743-8

By:

Abegesah, Aburough;
Oh, Do-Youn;
Lim, KyoungSoo;
Fan, Chunling;
Chen, Cecil;
Kim, Chong;
Wang, Julie;
Xynos, Ioannis;
Zotkiewicz, Magdalena;
Ren, Song;
Phipps, Alex;
Gibbs, Megan;
Zhou, Diansong

Publication type:

Article

A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.

Published in:

2017

By:

Sakai, Daisuke;
Chung, Hyun;
Oh, Do-Youn;
Park, Se;
Kadowaki, Shigenori;
Kim, Yeul;
Tsuji, Akihito;
Komatsu, Yoshito;
Kang, Yoon-Koo;
Uenaka, Kazunori;
Wijayawardana, Sameera;
Wacheck, Volker;
Wang, Xuejing;
Yamamura, Ayuko;
Doi, Toshihiko;
Chung, Hyun Cheol;
Park, Se Hoon;
Kim, Yeul Hong;
Wijayawardana, Sameera R

Publication type:

journal article

A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo.

Published in:

2017

By:

Ueno, Makoto;
Li, Chung;
Ikeda, Masafumi;
Ishii, Hiroshi;
Mizuno, Nobumasa;
Yamaguchi, Taketo;
Ioka, Tatsuya;
Oh, Do;
Ichikawa, Wataru;
Okusaka, Takuji;
Matsuyama, Yutaka;
Arai, Daichi;
Chen, Li;
Park, Young;
Furuse, Junji;
Li, Chung Pin;
Oh, Do Youn;
Chen, Li Tzong;
Park, Young Suk

Publication type:

journal article

A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1175, doi. 10.1007/s00280-015-2732-9

By:

Kim, Jin;
Choi, In;
Kim, Yu;
Lee, Kyung-Hun;
Lee, Keun-Wook;
Kim, Tae-Yong;
Han, Sae-Won;
Kim, Jee;
Kim, Tae-You;
Lee, Jong;
Bang, Yung-Jue;
Im, Seock-Ah;
Oh, Do-Youn

Publication type:

Article

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 447, doi. 10.1007/s00280-014-2515-8

By:

Lee, Keun-Wook;
Kim, Yu;
Lee, Kyung-Hun;
Han, Sae-Won;
Kim, Tae-Yong;
Oh, Do-Youn;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue;
Choi, In;
Kim, Jee

Publication type:

Article

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 5, p. 1023, doi. 10.1007/s00280-013-2268-9

By:

Kim, Ji-Won;
Kim, Jee;
Im, Seock-Ah;
Lee, Kyung-Hun;
Kim, Jin-Soo;
Kim, Tae-Yong;
Han, Sae-Won;
Jeon, Yoon;
Oh, Do-Youn;
Kim, Tae-You;
Park, In

Publication type:

Article

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 109, doi. 10.1007/s00280-013-2174-1

By:

Kim, Ji-Won;
Kim, Jee;
Im, Seock-Ah;
Kim, Yu;
Han, Hye-Suk;
Kim, Jin-Soo;
Lee, Kyung-Hun;
Kim, Tae-Yong;
Han, Sae-Won;
Jeon, Yoon;
Oh, Do-Youn;
Kim, Tae-You;
Park, In

Publication type:

Article

Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1435, doi. 10.1007/s00280-013-2141-x

By:

Kim, Jin;
Cho, Hyun;
Kim, Miso;
Lee, Kyung-Hun;
Kim, Min;
Han, Sae-Won;
Oh, Do-Youn;
Lee, Hyuk-Joon;
Im, Seock-Ah;
Kim, Tae-You;
Yang, Han-Kwang;
Kim, Woo;
Bang, Yung-Jue

Publication type:

Article

Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 843, doi. 10.1007/s00280-013-2075-3

By:

Lee, Kyung-Hun;
Chang, Hye;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Bang, Yung-Jue;
Kim, Sun;
Lee, Keun-Wook;
Kim, Jee;
Hong, Yong;
Kim, Tae;
Park, Young;
Kang, Won;
Shin, Sang;
Ahn, Joong;
Kang, Gyeong;
Jeong, Seung-Yong;
Park, Kyu;
Park, Jae-Gahb;
Kim, Tae-You

Publication type:

Article

Erratum to: Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.

Published in:

2013

By:

Kang, Yoon-Koo;
Kang, Byung;
Im, Seock-Ah;
Lee, Jae-Lyun;
Park, Sook;
Kang, Won;
Chang, Heung;
Kim, Tae;
Oh, Do-Youn;
Jung, Kyung;
Ryu, Min-Hee

Publication type:

Correction Notice

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 43, doi. 10.1007/s00280-012-1970-3

By:

Kang, Yoon-Koo;
Kang, Byung;
Im, Seock-Ah;
Lee, Jae-Lyun;
Park, Sook;
Kang, Won;
Chang, Heung;
Kim, Tae;
Oh, Do-Youn;
Jung, Kyung;
Ryu, Min-Hee

Publication type:

Article

Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1017, doi. 10.1007/s00280-011-1584-1

By:

Lim, Kyu-Hyoung;
Kim, Tae-Yong;
Lee, Kyung-Hun;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue

Publication type:

Article

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1045, doi. 10.1007/s00280-011-1586-z

By:

Park, Jin;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Jeong, Seung-Yong;
Park, Kyu;
Kim, Tae-You;
Bang, Yung-Jue;
Park, Jae-Gahb

Publication type:

Article

Prognostic implication of F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 165, doi. 10.1007/s00280-010-1454-2

By:

Shin, Dong-Yeop;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue

Publication type:

Article